Memorial Sloan Kettering medical oncologist Connie Lee Batlevi

Meet Medical Oncologist Connie Lee Batlevi

WATCH VIDEO 01:44

Connie Lee Batlevi, MD, PhD

Medical Oncologist

Clinical Expertise

Hodgkin Lymphoma; Non-Hodgkin Lymphoma

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Accepted Insurance Providers

Dr. Lee Batlevi accepts the following list of insurance providers. Select your insurance provider to see more details.

Contact and Location

Locations map

Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.

About Me

Education

MD, University of Massachusetts Medical School

Residencies

Internal Medicine - Mount Sinai Hospital/Mount Sinai School of Medicine

Fellowships

Hematology/Oncology - Memorial Sloan Kettering Cancer Center

Board Certifications

Internal Medicine; Oncology

I am a medical oncologist who cares for people with lymphoma. I am also a researcher who studies the disease. I am part of a team of world-class lymphoma experts who have more than 100 years of combined experience and a shared goal of providing the most effective, personalized care for people with this disease.

At MSK, we treat lymphoma with a variety of techniques, including chemotherapy, immunotherapy, targeted therapy, radiotherapy, and stem cell transplantation. Depending on each patient’s unique situation, some or all of these treatment methods may be used. We work together as a team to create a comprehensive care plan, starting with our scientific knowledge as the foundation.

My research focuses on lymphoma genetics, mechanism-based therapies for targeted therapy, and the application of chimeric antigen receptor T cells — called CAR T cells — in the treatment of lymphoma. I am currently involved in a number of clinical trials that are looking at immunotherapy, new combinations of drugs, and biomarker-based targeted therapies. Ultimately, my task as a clinical researcher is to understand the journey of each patient and to work to develop therapies that minimize the footprint lymphoma leaves on their lives.

I realize the devastation that a cancer diagnosis can cause in someone’s life, and the lives of their loved ones, and that treatment can be emotionally and logistically difficult. When people come to MSK, I hope they feel they have gained new advocates who will be with them throughout their entire journey. 

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

Clinical Trials

Smiling doctors in the lab

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Research and Publications

Batlevi C, Horwitz SM, Moskowitz CH, Zelenetz AD, Palomba L, et al. “Targeted Genomic Sequencing Prospectively Identifies Clinically Relevant Genetic Alterations Across Lymphoma Subtypes”; 13th International Conference on Malignant Lymphoma, Lugano, Switzerland, 2015. Oral Abstract.1.   

Batlevi CW, Kasamon Y, Bociek RG, Lee P, Gore L, Copeland A, Sorensen R, Ordentlich P, Cruickshank S, Kunkel L, Buglio D, Hernandez-Ilizaliturri F, Younes A. “ENGAGE- 501: Phase 2 Study of Entinostat (SNDX-275) in Relapsed and Refractory Hodgkin Lymphoma.” Haematologica. Epub 2016/05/05. pii: haematol.2016.142406. PMID: 27151994.

Batlevi CL, Younes A. Novel therapy for Hodgkin lymphoma. Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program. 2013;2013:394-9. Epub 2013/12/10. doi: 10.1182/asheducation-2013.1.394. PubMed PMID: 24319210.

Batlevi CL, Younes A. Diffuse large B-cell lymphoma: changing treatment paradigms. Oncology (Williston Park, NY). 2014;28(4):339-41. Epub 2014/05/21. PubMed PMID: 24839810.

Batlevi CL, Anas Y. “Hodgkin lymphoma microenvironment: old and new therapeutic targets”, Lymphoma, Volume 2, Future Medicine, 2014; 36-55. Ebook ISBN: 978-1-78084-582-1

Batlevi CL, Matsuki E, Brentjens RJ, Younes A. Novel immunotherapies in lymphoid malignancies. Nature reviews Clinical oncology. 2016;13(1):25-40. Epub 2015/11/04. doi: 10.1038/nrclinonc.2015.187. PubMed PMID: 26525683.

Publications on PubMed

Visit PubMed for a full listing of Dr. Lee Batlevi’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.